Effect of co-administration of probiotics with polysaccharide based colon targeted delivery systems to optimize site specific drug release

被引:35
作者
Prudhviraj, G. [1 ]
Vaidya, Yogyata [1 ]
Singh, Sachin Kumar [1 ]
Yadav, Ankit Kumar [1 ]
Kaur, Puneet [1 ]
Gulati, Monica [1 ]
Gowthamarajan, K. [2 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Ludhiana 144401, Punjab, India
[2] JSS Coll Pharm, Dept Pharmaceut, Ooty 643001, Tamil Nadu, India
关键词
Ulcerative colitis; Sulfasalazine; Spheroids; Probiotics; Colon targeted delivery system; Dissolution; INFLAMMATORY-BOWEL-DISEASE; SODIUM-INDUCED COLITIS; IN-VITRO EVALUATION; GUM MATRIX TABLETS; GUAR GUM; ULCERATIVE-COLITIS; HUMAN VOLUNTEERS; MODEL; AMYLOSE; RATS;
D O I
10.1016/j.ejpb.2015.09.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Significant clinical success of colon targeted dosage forms has been limited by their inappropriate release profile at the target site. Their failure to release the drug completely in the colon may be attributed to changes in the colonic milieu because of pathological state, drug effect and psychological stress accompanying the diseased state or, a combination of these. Alteration in normal colonic pH and bacterial picture leads to incomplete release of drug from the designed delivery system. We report the effectiveness of a targeted delivery system wherein the constant replenishment of the colonic microbiota is achieved by concomitant administration of probiotics along with the polysaccharide based drug delivery system. Guar gum coated spheroids of sulfasalazine were prepared. In the dissolution studies, these spheroids showed markedly higher release in the simulated colonic fluid. In vivo experiments conducted in rats clearly demonstrated the therapeutic advantage of co-administration of probiotics with guar gum coated spheroids. Our results suggest that concomitant use of probiotics along with the polysaccharide based delivery systems can be a simple strategy to achieve satisfactory colon targeting of drugs. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:164 / 172
页数:9
相关论文
共 60 条
  • [1] Prevalence of ulcerative colitis and Crohn's disease in Japan
    Asakura, Keiko
    Nishiwaki, Yuji
    Inoue, Nagamu
    Hibi, Toshifumi
    Watanabe, Mamoru
    Takebayashi, Toru
    [J]. JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 659 - 665
  • [2] AZADKHAN AK, 1977, LANCET, V2, P892
  • [3] Inflammatory bowel disease epidemiology
    Burisch, Johan
    Munkholm, Pia
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) : 357 - 362
  • [4] Guidelines for the management of inflammatory bowel disease in adults
    Carter, MJ
    Lobo, AJ
    Travis, SPL
    [J]. GUT, 2004, 53 : v1 - v16
  • [5] Chapman MA, 2001, ANN ROY COLL SURG, V83, P75
  • [6] Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease
    Conte, M. P.
    Schippa, S.
    Zamboni, I.
    Penta, M.
    Chiarini, F.
    Seganti, L.
    Osborn, J.
    Falconieri, P.
    Borrelli, O.
    Cucchiara, S.
    [J]. GUT, 2006, 55 (12) : 1760 - 1767
  • [7] Epidemiology and Natural History of Inflammatory Bowel Diseases
    Cosnes, Jacques
    Gower-Rousseau, Corinne
    Seksik, Philippe
    Cortot, Antoine
    [J]. GASTROENTEROLOGY, 2011, 140 (06) : 1785 - U118
  • [8] THE INVIVO EVALUATION OF AN OSMOTIC DEVICE (OSMET) USING GAMMA SCINTIGRAPHY
    DAVIS, SS
    HARDY, JG
    TAYLOR, MJ
    STOCKWELL, A
    WHALLEY, DR
    WILSON, CG
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1984, 36 (11) : 740 - 742
  • [9] Recent advances in understanding ulcerative colitis
    Di Sabatino, Antonio
    Biancheri, Paolo
    Rovedatti, Laura
    MacDonald, Thomas Thornton
    Corazza, Gino Roberto
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (02) : 103 - 111
  • [10] Inflammatory bowel disease: Etiology and pathogenesis
    Fiocchi, C
    [J]. GASTROENTEROLOGY, 1998, 115 (01) : 182 - 205